Boronation of antibodies with mercaptoundecahydro-closo-dodecaborate(2-) anion for potential use in boron neutron capture therapy
- 1 January 1987
- journal article
- research article
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 38 (7) , 503-506
- https://doi.org/10.1016/0883-2889(87)90195-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Current status of 10B-neutron capture therapy: Enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: A theoretical evaluationInternational Journal of Radiation Oncology*Biology*Physics, 1985
- [1] Preparation of monoclonal antibodies: Strategies and proceduresPublished by Elsevier ,1981
- High-resolution microanalysis of biological specimens by electron energy loss spectroscopy and by electron spectroscopic imagingJournal of Ultrastructure Research, 1980
- Fusion between immunoglobulin‐secreting and nonsecreting myeloma cell linesEuropean Journal of Immunology, 1976
- Interaction between serum albumin and mercaptoundecahydrododecaborate ion (an agent for boron-neutron capture therapy of brain tumor). II. Proposal of two interaction models.CHEMICAL & PHARMACEUTICAL BULLETIN, 1975
- Interaction between serum albumin and mercaptoundecahydrododecaborate ion (an agent for boron-neutron capture therapy of brain tumor). I. Introductory remarks and preliminary experiments.CHEMICAL & PHARMACEUTICAL BULLETIN, 1975
- Penetration of Brain and Brain Tumor. VII. Tumor-Binding Sulfhydryl Boron CompoundsJournal of Medicinal Chemistry, 1967
- Determination of Hydrolytically-Stable Boron Hydrides in Biological Materials.Analytical Chemistry, 1964
- TRITIUM-LABELING BY EXPOSURE OF ORGANIC COMPOUNDS TO TRITIUM GAS1Journal of the American Chemical Society, 1957